← Back to All US Stocks

OneMedNet Corp (ONMDW) Stock Fundamental Analysis & AI Rating 2026

ONMDW Nasdaq Services-Commercial Physical & Biological Research DE CIK: 0001849380
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
STRONG SELL
97% Conf
Pending
Analysis scheduled

📊 ONMDW Key Takeaways

Revenue: $1.4M
Net Margin: -206.1%
Free Cash Flow: $-7.5M
Current Ratio: 0.43x
Debt/Equity: N/A
EPS: $-0.06
AI Rating: STRONG SELL with 97% confidence
OneMedNet Corp (ONMDW) receives a STRONG SELL rating with 97% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $1.4M, net profit margin of -206.1%, OneMedNet Corp demonstrates mixed fundamentals in the Healthcare sector. Below is our complete ONMDW stock analysis for 2026.

Is OneMedNet Corp (ONMDW) a Good Investment?

Claude

OneMedNet faces an existential financial crisis with negative stockholders' equity of -$3.0M, indicating technical insolvency. The company burns $7.5M annually in operating cash while generating only $1.4M in flat revenue and $585K in cash reserves, providing less than one month of operational runway. Without immediate capital infusion or dramatic operational turnaround, the company faces imminent bankruptcy risk.

Why Buy OneMedNet Corp Stock? ONMDW Key Strengths

Claude
  • + Net loss improved 72.3% year-over-year, demonstrating some cost control progress
  • + Manageable long-term debt of only $220K relative to total liabilities
  • + Maintains modest cash position of $585K as emergency buffer

ONMDW Stock Risks: OneMedNet Corp Investment Risks

Claude
  • ! Negative stockholders' equity of -$3.0M - company is technically insolvent
  • ! Critical liquidity crisis: current ratio of 0.43x cannot cover short-term obligations; <1 month cash runway at current burn rate
  • ! Revenue stagnation with negative gross margin (-37%) indicates fundamental business model failure - losing money on every transaction
  • ! Operating margin of -711% reflects severe structural unprofitability with no visible path to positive operations
  • ! Zero insider buying activity in 90 days signals management lacks confidence in turnaround

Key Metrics to Watch

Claude
  • * Cash balance and monthly burn rate - company faces imminent capital crisis
  • * Revenue growth and gross margin improvement - currently flat and deeply negative
  • * Ability to secure emergency financing or capital injection required for survival

OneMedNet Corp (ONMDW) Financial Metrics & Key Ratios

Revenue
$1.4M
Net Income
$-2.8M
EPS (Diluted)
$-0.06
Free Cash Flow
$-7.5M
Total Assets
$2.2M
Cash Position
$585.0K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

ONMDW Profit Margin, ROE & Profitability Analysis

Gross Margin -37.0%
Operating Margin -711.3%
Net Margin -206.1%
ROE N/A
ROA -130.2%
FCF Margin -553.1%

ONMDW vs Healthcare Sector: How OneMedNet Corp Compares

How OneMedNet Corp compares to Healthcare sector averages

Net Margin
ONMDW -206.1%
vs
Sector Avg 12.0%
ONMDW Sector
ROE
ONMDW 0.0%
vs
Sector Avg 15.0%
ONMDW Sector
Current Ratio
ONMDW 0.4x
vs
Sector Avg 2.0x
ONMDW Sector
Debt/Equity
ONMDW 0.0x
vs
Sector Avg 0.6x
ONMDW Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is OneMedNet Corp Stock Overvalued? ONMDW Valuation Analysis 2026

Based on fundamental analysis, OneMedNet Corp has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
-206.1%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

OneMedNet Corp Balance Sheet: ONMDW Debt, Cash & Liquidity

Current Ratio
0.43x
Quick Ratio
0.43x
Debt/Equity
N/A
Debt/Assets
237.8%
Interest Coverage
-175.76x
Long-term Debt
$220.0K

ONMDW Revenue & Earnings Growth: 5-Year Financial Trend

ONMDW 5-year financial data: Year 2023: Revenue $1.2M, Net Income -$6.2M, EPS $-0.98. Year 2024: Revenue $1.0M, Net Income -$33.8M, EPS $-4.65. Year 2025: Revenue $1.4M, Net Income -$10.1M, EPS $-0.36.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: OneMedNet Corp's revenue has grown significantly by 18% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.36 indicates the company is currently unprofitable.

ONMDW Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-553.1%
Free cash flow / Revenue

ONMDW Quarterly Earnings & Performance

Quarterly financial performance data for OneMedNet Corp including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $142.0K $339.0K $0.01
Q2 2025 $155.0K $1.1M $0.03
Q1 2025 $137.0K -$1.9M $-0.06
Q3 2024 $142.0K -$2.1M $-0.07
Q2 2024 $173.0K -$2.1M $-0.15
Q1 2024 $200.0K -$2.1M $-0.09
Q3 2023 $680.9K -$1.7M $0.29

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

OneMedNet Corp Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$7.5M
Cash generated from operations
Capital Expenditures
$13.0K
Investment in assets
Dividends
None
No dividend program

ONMDW SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for OneMedNet Corp (CIK: 0001849380)

📋 Recent SEC Filings

Date Form Document Action
Mar 30, 2026 10-K form10-k.htm View →
Dec 23, 2025 4 xslF345X05/ownership.xml View →
Dec 23, 2025 8-K form8-k.htm View →
Nov 26, 2025 4 xslF345X05/ownership.xml View →
Nov 26, 2025 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about ONMDW

What is the AI rating for ONMDW?

OneMedNet Corp (ONMDW) has an AI rating of STRONG SELL with 97% confidence, based on fundamental analysis of SEC EDGAR filings.

What are ONMDW's key strengths?

Claude: Net loss improved 72.3% year-over-year, demonstrating some cost control progress. Manageable long-term debt of only $220K relative to total liabilities.

What are the risks of investing in ONMDW?

Claude: Negative stockholders' equity of -$3.0M - company is technically insolvent. Critical liquidity crisis: current ratio of 0.43x cannot cover short-term obligations; <1 month cash runway at current burn rate.

What is ONMDW's revenue and growth?

OneMedNet Corp reported revenue of $1.4M.

Does ONMDW pay dividends?

OneMedNet Corp does not currently pay dividends.

Where can I find ONMDW SEC filings?

Official SEC filings for OneMedNet Corp (CIK: 0001849380) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is ONMDW's EPS?

OneMedNet Corp has a diluted EPS of $-0.06.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is ONMDW a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, OneMedNet Corp has a STRONG SELL rating with 97% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is ONMDW stock overvalued or undervalued?

Valuation metrics for ONMDW: ROE of N/A (sector avg: 15%), net margin of -206.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy ONMDW stock in 2026?

Our dual AI analysis gives OneMedNet Corp a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is ONMDW's free cash flow?

OneMedNet Corp's operating cash flow is $-7.5M, with capital expenditures of $13.0K. FCF margin is -553.1%.

How does ONMDW compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -206.1% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.43 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI